CAPITALSTARS
TOP CORPORATE NEWS

Aurobindo Pharma receives USFDA
approval for Aripiprazole Tablets
Aurobindo Pharma
Limited has received the final approval from the US Food & Drug Administration
( USFDA) to manufacture and market Aripiprazole Tablets, 2mg, 5mg, 10mg, 15mg,
20mg and 30mg. The product is ready for launch. Aripiprazole Tablets are
indicated in the treatment symptoms of psychotic conditions such as
schizophrenia and bipolar disorder (manic depression).
Patanjali ties up with Future
group for distribution
Patanjali products
ties up with Future group for distribution of its products- Aims to reach
Rs1000 crore turnover in 20 months through distribution- Positive for Future
group ( Future Retail + Future Consumer Enterprises).
Apollo Hospitals to raise
Rs1,000 crore for expansion
Apollo Hospitals
to raise Rs1,000 crore for expansion; set to open 150 clinics by 2015-end
(already set up 38 clinics) – positive read through for the stock.
Redington surges as arm gets
iPhone distributorship
Redington rose
nearly 6%, touching to Rs123.8, after the company said its subsidiary has been
appointed as a distributor for Apple iPhones in the UAE with immediate effect.
Redington (India) announced that Redington Gulf FZE, a step-down subsidiary of
the company, has been appointed by US-based Apple Inc as a distributor for
iPhones in the UAE with immediate effect.
Torrent Pharma board approves
amalgamation of Zyg Pharma
Torrent Pharma
board approves amalgamation of Zyg Pharma – Positive for long term. The Board
of Directors of Torrent Pharmaceuticals has approved the scheme of amalgamation
of Zyg Pharma Pvt Ltd a wholly owned subsidiary of the company with Torrent
Pharmaceuticals. The amalgamation is yet subject to regulatory approvals.
Fortis gains after SRL
Diagnostic plans Rs1,250 crore share sale
Shares of Fortis
Healthcare gained 3% to Rs173 on NSE after the Fortis-owned SRL Diagnostic
planned Rs1,250-crore share sale to help some existing investors monetized its
minority holding; SRL has scrapped its IPO plans in near future – sentimentally
negative for Fortis Healthcare as listing of SRL Diagnostic was one of the
triggers for the stock.
Lords Ishwar receives Liquor
Licence from Gujarat
Lords Ishwar
Hotels Ltd has informed that the Company has received the Liquor Licence from
Superintendent of Prohibition & Excise Department, Vadodara to sell foreign
liquor at its premises to the permit holders under the provisions of the
Gujarat Prohibition Act, 1949.

Aurobindo Pharma receives USFDA
approval for Aripiprazole Tablets
Aurobindo Pharma
Limited has received the final approval from the US Food & Drug Administration
( USFDA) to manufacture and market Aripiprazole Tablets, 2mg, 5mg, 10mg, 15mg,
20mg and 30mg. The product is ready for launch. Aripiprazole Tablets are
indicated in the treatment symptoms of psychotic conditions such as
schizophrenia and bipolar disorder (manic depression).
Patanjali ties up with Future
group for distribution
Patanjali products
ties up with Future group for distribution of its products- Aims to reach
Rs1000 crore turnover in 20 months through distribution- Positive for Future
group ( Future Retail + Future Consumer Enterprises).
Apollo Hospitals to raise
Rs1,000 crore for expansion
Apollo Hospitals
to raise Rs1,000 crore for expansion; set to open 150 clinics by 2015-end
(already set up 38 clinics) – positive read through for the stock.
Redington surges as arm gets
iPhone distributorship
Redington rose
nearly 6%, touching to Rs123.8, after the company said its subsidiary has been
appointed as a distributor for Apple iPhones in the UAE with immediate effect.
Redington (India) announced that Redington Gulf FZE, a step-down subsidiary of
the company, has been appointed by US-based Apple Inc as a distributor for
iPhones in the UAE with immediate effect.
Torrent Pharma board approves
amalgamation of Zyg Pharma
Torrent Pharma
board approves amalgamation of Zyg Pharma – Positive for long term. The Board
of Directors of Torrent Pharmaceuticals has approved the scheme of amalgamation
of Zyg Pharma Pvt Ltd a wholly owned subsidiary of the company with Torrent
Pharmaceuticals. The amalgamation is yet subject to regulatory approvals.
Fortis gains after SRL
Diagnostic plans Rs1,250 crore share sale
Shares of Fortis
Healthcare gained 3% to Rs173 on NSE after the Fortis-owned SRL Diagnostic
planned Rs1,250-crore share sale to help some existing investors monetized its
minority holding; SRL has scrapped its IPO plans in near future – sentimentally
negative for Fortis Healthcare as listing of SRL Diagnostic was one of the
triggers for the stock.
Lords Ishwar receives Liquor
Licence from Gujarat
Lords Ishwar
Hotels Ltd has informed that the Company has received the Liquor Licence from
Superintendent of Prohibition & Excise Department, Vadodara to sell foreign
liquor at its premises to the permit holders under the provisions of the
Gujarat Prohibition Act, 1949.
Read more at:
Our Some Other Tips & Services, Get it Soon !!
Read more at:
Our Some Other Tips & Services, Get it Soon !!
www.capitalstars.com | T:+91-731-6790000,6669900
www.capitalstars.com | T:+91-731-6790000,6669900
0 comments:
Post a Comment